Eukaryotic initiation factor 2α phosphorylation is required for B cell maturation and function in mice by Mielke, N. et al.
Eukaryotic initiation factor 2a phosphorylation is required for B cell
maturation and function in mice
by Nina Mielke, Rolf Schwarzer, Cornelis F. Calkhoven, Randal J. Kaufman, 
Bernd Dorken, Achim Leutz, and Franziska Jundt  
Haematologica 2011 [Epub ahead of print]
Citation: Mielke N, Schwarzer R, Calkhoven CF, Kaufman RJ, Dorken B, Leutz A, 
and Jundt F. Eukaryotic initiation factor 2a phosphorylation is required for B cell maturation
and function in mice. Haematologica. 2011; 96:xxx 
doi:10.3324/haematol.2011.042853
Publisher's Disclaimer. 
E-publishing ahead of print is increasingly important for the rapid dissemination of science.
Haematologica is, therefore, E-publishing PDF files of an early version of manuscripts that
have completed a regular peer review and have been accepted for publication. E-publishing
of this PDF file has been approved by the authors. After having E-published Ahead of Print,
manuscripts will then undergo technical and English editing, typesetting, proof correction and
be presented for the authors' final approval; the final version of the manuscript will then
appear in print on a regular issue of the journal. All legal disclaimers that apply to the 
journal also pertain to this production process.
Haematologica (pISSN: 0390-6078, eISSN: 1592-8721, NLM ID: 0417435, www.haemato-
logica.org) publishes peer-reviewed papers across all areas of experimental and clinical
hematology. The journal is owned by the Ferrata Storti Foundation, a non-profit organiza-
tion, and serves the scientific community with strict adherence to the principles of open
access publishing (www.doaj.org). In addition, the journal makes every paper published
immediately available in PubMed Central (PMC), the US National Institutes of Health (NIH)
free digital archive of biomedical and life sciences journal literature. 
Official Organ of the European Hematology Association
Published by the Ferrata Storti Foundation, Pavia, Italy
www.haematologica.org
Early Release Paper
Support Haematologica and Open Access Publishing by becoming a member of the European Hematology Association (EHA)
and enjoying the benefits of this membership, which include free participation in the online CME program
 Copyright 2011 Ferrata Storti Foundation.
Published Ahead of Print on May 12, 2011, as doi:10.3324/haematol.2011.042853.
DOI: 10.3324/haematol.2011.042853 
 
Eukaryotic initiation factor 2α  phosphorylation is required for B cell 
maturation and function in mice 
Nina Mielke1, Rolf Schwarzer1, Cornelis F. Calkhoven2,3, Randal J. Kaufman,4,5 Bernd Dörken1,2, 
Achim Leutz2, and Franziska Jundt1,2 
1Department of Hematology and Oncology, Charité, Campus Virchow-Klinikum, University 
Medicine Berlin, D-13353 Berlin, Germany, and 2Max Delbrück Center for Molecular Medicine,  
D-13092 Berlin, Germany 
 
3Present address: Leibniz Institute for Age Research-Fritz Lipmann Institute, D-07745 Jena, 
Germany; 4Departments of Biological Chemistry and 5Internal Medicine University of Michigan 
Medical Center, Ann Arbor, MI 48109, USA 
 
Correspondence 
Franziska Jundt, Med. Klinik. m.S. Hämatologie und Onkologie, Charité, Campus Virchow-
Klinikum, Augustenburger Platz 1, 13353 Berlin, Germany. Phone: international +0049.30.45 
559399. Fax: international +0049.30.450559929. E-mail: franziska.jundt@charite.de  
 
Achim Leutz, Max Delbrück Center for Molecular Medicine, Robert-Rössle-Str. 10, 13092 Berlin, 
Germany, Phone: international +0049.30.45 559399.00. Fax: international +49.30.94063298.  E-
mail: aleutz@mdc-berlin.de. 
 
Running title: Phosphorylation of eIF2α in B cell development 
 
DOI: 10.3324/haematol.2011.042853 
 
 2 
Abstract 
Background 
The control of translation initiation is a crucial component in the regulation of gene 
expression. The eukaryotic initiation factor 2α (eIF2α) mediates binding of the initiator 
transfer-messenger-RNA (tmRNA) to the AUG initiation codon, and thus controls a rate-
limiting step in translation initiation. Phosphorylation of eIF2α at serine 51 (S51) is linked to 
cellular stress response and attenuates translation initiation. The biochemistry of translation 
inhibition mediated by eIF2α phosphorylation is well characterized, yet the physiological 
importance in hematopoiesis remains only partially known.  
Design and Methods 
Using hematopoietic stem cells carrying a non-phosphorylatable mutant form of eIF2α 
(eIF2αAA), we examined the efficiency of reconstitution in wildtype or B cell-deficient 
microMT C57BL/6 recipients in two independent models. 
Results 
We provide evidence that phosphorylation-deficient eIF2α mutant hematopoietic stem cells 
may repopulate lethally irradiated mice but have a defect in the development and 
maintenance of newly formed B cells in the bone marrow and of naïve follicular B cells in the 
periphery. The mature B cell compartment is markedly reduced in bone marrow, spleen and 
peripheral blood, and B cell receptor (BCR)-mediated proliferation in vitro and serum 
immunoglobulin secretion in vivo are impaired.  
Conclusions 
The data suggest that regulation of translation through eIF2α phosphorylation is dispensable 
in hematopoietic reconstitution but essential during late B cell development. 
 
Keywords: hematopoietic stem cells, eIF2α phosphorylation, B cell development, mouse model, 
translation initiation. 
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Introduction  
The regulation of translation is an important mechanism that modulates gene expression 
during embryonic development, cell differentiation and metabolism.1 There is increasing 
evidence that the regulated function of translation initiation factors is essential for 
hematopoietic differentiation and that their deregulation contributes to leukemogenesis.2-6 
Furthermore, the eukaryotic translation initiation factor 4E (eIF4E) acts as a promoter of 
nucleo-cytoplasmic transport of distinct transcripts and its deregulation is associated with 
acute and chronic myelogenous leukemias.5 However, the importance of regulated functions 
of the key translation initiation factor 2 (eIF2) during hematopoietic differentiation is largely 
unknown. 
The α subunit of eIF2 is subject to negative regulation by phosphorylation. Phosphorylation 
of eIF2α at serine 51 (S51) is required for cell survival in response to accumulation of 
unfolded proteins in the ER, translation attenuation and transcriptional induction.7,8 Mice that 
carry the non-phosphorylatable homozygous eIF2αS51A mutation (eIF2αAA) die within 18 
hours after birth due to hypoglycemia associated with defective gluconeogenesis.7 The 
homozygous mutant embryos have a deficiency in pancreatic β cells.7 Further analysis of the 
knock-in mutant eIF2α-AA mouse embryonic fibroblasts (MEFs) exhibited an increased basal 
translation rate and showed that phosphorylation of eIF2α is necessary to inhibit global 
protein synthesis under conditions of ER stress.7 The biochemical mechanism of translation 
inhibition mediated by eIF2α phosphorylation is well characterized, however, little is known 
about the physiological implications in regeneration and in stem cell biology.1 In its GTP-
bound form eIF2 is part of a ternary complex that binds methionine-loaded initiator tRNA and 
recognizes the AUG start codon during initiation. After the initiator AUG has been 
recognized, GTP is hydrolyzed to GDP. The exchange of GDP for GTP is necessary for 
reconstitution of the ternary complex. This GTP-exchange reaction is blocked by 
phosphorylation of the α subunit of eIF2. Four kinases may phosphorylate eIF2α at S51: (1) 
the amino acid control kinase GCN2 (general control non-derepressible-2), (2) the heme-
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regulated HRI (haem-regulated inhibitor), (3) the double-stranded RNA-activated protein 
kinase PKR and (4) PERK, which is activated in response to endoplasmic reticulum (ER) 
stress via a branch of the “unfolded protein response” (UPR) to prevent overload of the 
secretory pathway. Whether regulated eIF2α phosphorylation is important during 
hematopoietic recovery has been only partially addressed.6  
During T helper cell differentiation and execution of effector functions such as cytokine 
secretion the regulated activity of eIF2α is needed to direct this process after T cell receptor 
priming in mice.3 In line with these data a recent report showed that during human 
inflammatory T cell differentiation of T helper 17 cells, which are characterized by production 
of interleukin-17, phosphorylation of eIF2α after amino acid starvation is required for this 
inflammatory response.4 However, the role of controlled eIF2α phosphorylation for B cell 
development and antibody secretion are not fully explored.6 It has been shown that the 
proximal sensor of the UPR the inositol-requiring enzyme 1α (IRE1α) is required in B cell 
lymphopoiesis in a B and T cell-deficient rag2-/- BALB/c background. However, under these 
conditions the PERK/eIF2α UPR signaling was found to be dispensable for B cell 
development.6  
By two independent strategies we examined the efficiency of reconstitution by hematopoietic 
stem cells carrying a non-phosphorylatable S51A mutant form of eIF2α (eIF2αAA) in wildtype 
(WT) or B cell-deficient microMT(µMT) C57BL/6 recipients. We show that eIF2α 
phosphorylation is dispensable during hematopoietic reconstitution and lineage commitment 
but is required for the development and maintenance of newly formed B cells in the bone 
marrow and of naïve follicular B (FOB) cells in the periphery. Hence, eIF2α phosphorylation 
may play a more important role in B cell development than was anticipated from previous 
studies. 
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Design and Methods 
Viral transduction of fetal liver cells and transplantation 
The pcDNA3-eIF2α-SA plasmid was constructed as previously described.9 The eIF2α-SA-
HA DNA fragment was subcloned into the bicistronic GFP-expressing retroviral vector 
MIGR1.10 We used the calcium phosphate-mediated transfection (Calcium Phosphate 
Transfection Kit, Invitrogen, Karlsruhe, Germany) of viral vector DNA into ecoPhoenix cells to 
produce viral supernatants. WT mice (C57BL/6) were crossed to produce embryos that were 
removed at E12-E14. The fetal livers were isolated, disrupted into a cell suspension and 
cultured in 50% DMEM, 50% IMDM, 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin, 
2 mM l-alanyl-l-glutamin, 50 µM 2-mercaptoethanol, 50 ng/ml mouse stem cell factor, 10 
ng/ml interleukin (IL)-3 and 10 ng/ml IL-6 for approximately 10 h. Fetal liver cells were 
infected three times by virus in the presence of RetroNectin® (TaKaRa, Cambrex Bio, Apen, 
Germany) according to the manufacturers protocol at intervals of 12 hours. 2 x 106 
transfected cells were then transplanted into irradiated (800 rad) WT mice (C57BL/6) through 
tail vein injection. 
 
Generation of eIF2α  chimeric mice 
eIF2α mice were generated as previously described.7 Mice were genotyped by PCR using 
the following primers: eIF-2/3 5´-CAATGTTGTAGACCCTGACAATGAAGG-3´ and eIF-2/5 
5´-CACACACCCATTCCATGATAGTAAATG-3´. The expected sizes of the PCR products are 
500 bp for the mutant allele and 410 bp for the WT allele. All mouse experiments were 
approved by the local committee of the Landesamt für Arbeitsschutz, Gesundheitsschutz und 
technische Sicherheit Berlin (Berlin, Germany). 
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Isolation, transplantation, and culture of fetal liver cells 
Heterozygous eIF2α-SA (CD45.2) mice were crossed to produce embryos that were 
removed at E12-E14 and the fetal livers were isolated. For each embryo, the head was 
collected for genotyping, and the fetal livers were disrupted into a cell suspension. Fetal liver 
cells (2 x 106) were transplanted into irradiated (800 rad) µMT (CD45.1) mice through tail 
vein injection.  
 
Cell sorting and immunoblotting 
For magnetic cell sorting of resting splenic B cells an isolation kit (Miltenyi Biotec) was used 
as previously described.11 Whole cell extracts were prepared and quantitated by Bradford 
protein assay.12  Proteins (30 µg) were resolved by SDS-PAGE and transferred to 
nitrocellulose membranes. Protein load was normalized by Ponceau red staining and β-actin. 
Membranes were incubated with mouse monoclonal anti-HA (6E2, Cell Signaling 
Technology), rabbit monoclonal anti-eIF2α (D7D3, Cell Signaling Technology) and rabbit 
monoclonal anti-β-actin antibodies (13E5, Cell Signaling Technology), followed by HRP-
conjugated secondary antibodies (Santa Cruz, Heidelberg, Germany) and detected by 
enhanced chemiluminescence (Amersham, Munich, Germany). 
 
Flow cytometry analysis and antibodies 
The following monoclonal antibodies were used: Flourescein isothiocyanate (FITC)-
conjugated anti-CD45.2 (104), anti-Ly-51 (6C3/BP-1 antigen) and anti-CD43 (S7), 
phycoerythrin (PE)-conjugated anti-CD45.1 (A20), anti-CD43 (S7), anti-CD21 (7G6, all BD 
Pharmingen), anti-IgD (11-26, Southern Biotech), anti-CD90 (CT-TH1), and anti-IgM 
(M31504), PE-Cy5.5-conjugated anti-CD45R (B220, RA3-6B2), biotin-conjugated anti-CD24 
(CT-HSA), anti-CD23 (B3B4) and anti-IgM (RMGM15, all Caltag, Hamburg, Germany), 
allophycocyanin (APC)-conjugated anti-CD19 (1D3, BD Pharmingen) and Streptavidin-
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conjugated PerCP and APC. All analyses were performed with FACSCalibur and CellQuest 
software (BD Bioscience).  
 
 
Blood counts 
20 µl EDTA-anti-coagulated blood samples were used to obtain a complete blood count with 
a Sysmex, XE-2100 (Norderstedt, Germany).  
 
Proliferation assay 
For assaying proliferation of cells CellTiter-Glo Luminescent Cell Viability Assay (Promega, 
Mannheim, Germany) was used. Assay was carried out according to manufacturer’s 
protocol. Briefly, cells were plated in 96-well plates at 10,000 cells per well in 100 µl medium 
and treated with indicated amounts of LPS (Sigma), or IgM F(ab)2 (Jackson Immuno 
Research Laboratories; West Grove, USA). Experiments were performed in three 
independent replicates. 72 h after treatment 30 µl per well were transferred into an opaque-
walled plate and lysed using CellTiter-Glo solution. Average values were calculated and 
normalized to the respective untreated sample. 
 
ELISA 
ELISA were conducted using affinity-purified anti-mouse IgM, IgG1, IgG2a, and IgG2b (all 
Becton Dickinson) to generate standard curves. To determine concentration of Ig 2 µg of rat 
anti-mouse isotype-specific antibodies (Becton Dickinson) were used as capture agents. 
Appropriate dilution of serum samples were loaded for 1 h, followed by addition of biotin-
conjugated anti-mouse isotype-specific antibodies and streptavidin-peroxidase-conjugate 
(Sigma). o-Phenylenediamine (Sigma) was used as a substrate. Enzyme activities were 
measured at 450 nm in a microplate spectrophotometer (BioRad, Munich, Germany). 
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Statistical analysis 
Statistics were performed using the Mann-Whitney U test. 
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Results  
Reconstitution of fetal liver chimera 
Two approaches were chosen to investigate the role of eIF2α phosphorylation in 
hematopoiesis of the mouse. First, we generated retroviral vectors that express the HA-
tagged mutant form of eIF2α (MIGR1-eIF2α-SA). The S51 phosphorylation site of the eIF2α 
coding sequence was mutated to a non-phosphorylatable alanine residue (S51A). We 
transduced WT fetal liver cells from C57BL/6 embryos at E14 with control MIGR1 and 
MIGR1-eIF2α-SA vectors and transplanted these cells into irradiated C57BL/6 mice (Figure 
1A). Two and four months after transplantation, peripheral blood from transplanted C57BL/6 
WT mice was analyzed by flow cytometry analysis for GFP expression (Figure 1B). Whereas 
almost 80% of mononuclear cells in the peripheral blood derived from WT (MIGR1-
transduced) fetal liver cells were GFP positive, only 10% of cells from mutant eIF2α (MIGR1-
eIF2α-SA transduced) fetal liver cells showed GFP positivity two months after transplantation 
(Figure 1B). However, immunoblotting of whole cell extracts from splenic B and non-B cells 
of mice transplanted with MIGR1-eIF2α-SA transduced fetal liver cells revealed substantial 
expression of the HA-tagged eIF2α mutant protein (eIF2α-SA-HA; Figure 1A,C). Previously, 
it has been described that for IRES-dependent gene expression the phosphorylation of eIF2α 
is indispensable.13-15 These data suggest that in mice transplanted with MIGR1-eIF2α-SA 
transduced fetal liver cells hematopoietic cells highly express the HA-tagged mutant form of 
eIF2α (MIGR1-eIF2α-SA) that competes for WT eIF2α, which is necessary for IRES-
mediated GFP expression. Therefore, we suggest that GFP expression does not correlate 
with the transduction efficiency in MIGR1-eIF2α-SA transduced hematopoietic cells. 
Second, fetal liver cells isolated from the homozygous eIF2α knock-in embryos (Ser51/Ala; 
eIF2α-AA;7) and WT embryos (eIF2α-SS) at E14 were transplanted into irradiated B cell-
deficient µMT mice to reconstitute the hematopoietic system (Figure 1D). Due to the 
phosphorylation defect of eIF2α the basal translation rate is increased in mutant (eIF2α-AA) 
as compared to WT (eIF2α-SS) cells.7 The irradiated C57BL/6 and µMT mice died within 12 
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days after irradiation without transplantation. In contrast, mice reconstituted with retrovirally 
transduced (MIGR1; MIGR1-eIF2α-SA), knock-in mutant (eIF2α-AA) or WT (eIF2α-SS) fetal 
liver cells survived 10 months and longer. Flow cytometry analysis of the bone marrow 
(Figure 1E) and peripheral blood (Figure 1F) of fetal liver chimera revealed 90% donor cells 
(CD45.2 positive) in mice reconstituted with WT (eIF2α-SS) and mutant (eIF2α-AA) cells 
over a 10-month period. Remaining hematopoietic cells of the recipient µMT mice were 
CD45.1 positive (Figure 1E). In this study we generated two different mouse models where 
hematopoietic recovery of stem cells occurs, which express the phosphorylation-deficient 
mutant form of eIF2α. 
 
B cell development is impaired in phosphorylation-deficient eIF2α  stem cells 
To analyze whether eIF2α phosphorylation is implicated in hematopoiesis, we performed 
differential blood counts in reconstituted (1) C57BL/6 WT and (2) B cell-deficient µMT 
recipients as described above (Figure 1A,D). Differential blood counts in mice transplanted 
with mutant (MIGR1-eIF2α-SA and eIF2α-AA) as compared to WT (MIGR1, eIF2α-SS) fetal 
liver cells revealed a 50% reduction of the number of white blood cells (WBC; Table 1). 
Interestingly, this reduction was due to a decrease in the number of lymphocytes (Table1 and 
Figure 2A,B), whereas the number of neutrophils (NEU) and all other WBC which were 
analyzed remained unchanged. Numbers of red blood cells (RBC) and platelets (PLT) were 
also not different between the groups (Table 1). Flow cytometry analysis with antibodies 
against the B cell antigen CD19 revealed that the reduction of lymphocytes in mutant eIF2α 
mononuclear cells in the peripheral blood was due to diminished B cell numbers rather than 
T cell numbers (CD90) in both models (Figure 2C,D). Accordingly, T cell subset analysis with 
the markers CD3, CD4, CD8 and analysis of the myeloid compartment using Gr-1, CD11b 
did not reveal differences between mice transplanted with mutant as compared to WT fetal 
liver cells (data not shown). Although we were unable to exactly quantify the degree of 
reconstitution in C57/BL6 WT mice transplanted with retrovirally transduced mutant eIF2α 
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(MIGR1-eIF2α-SA) fetal liver cells (Figure 1B,C) by GFP expression, we received remarkably 
similar results in the two different models (C57BL/6 WT and B cell-deficient µMT). 
To determine B lineage maturation in the bone marrow as previously described,16 we 
analyzed mononuclear cells of µMT mice reconstituted with WT (eIF2α-SS) and mutant 
(eIF2α-AA) fetal liver cells by flow cytometry analysis (Figure 3). Within the CD43+B220+ B 
cell compartment, pre-pro B cells (A), pro B cells (B) and large pre-B cells (C) can be 
distinguished by antibodies against CD24 and BP1. In the CD43-B220+ fraction we analyzed 
small pre-B cells (D) as well as immature (E) and mature (F) B cells using the B cell surface 
immunoglobulin markers IgM and IgD. A marked reduction in the number of IgM+IgD+ mature 
B cells was found in mice with mutant eIF2α (eIF2α-AA) as compared to WT controls (eIF2α-
SS), whereas all other B cell compartments remained unchanged (Figure 3A-F). These data 
suggest that eIF2α phosphorylation is dispensable for the hematopoietic reconstitution of all 
hematopoietic lineages analyzed except of B220+IgM+IgD+ mature B cells. 
 
Functional impairment of antibody-secreting B cells through deficient eIF2α  
phosphorylation 
Immature B cells in the bone marrow receive signals to home to the spleen to complete 
maturation.17 Therefore, we investigated B cell maturation of splenic B cells in µMT mice 
reconstituted with WT (eIF2α-SS) and mutant (eIF2α-AA) fetal liver cells. Spleen weight and 
size in mice with mutant eIF2α hematopoietic cells were significantly reduced compared to 
WT controls (Figure 4A). Flow cytometry analysis of the splenic T and B cell compartments 
revealed that the number of mature CD19+IgM+IgD+ B cells was diminished (Figure 4B,C). In 
the spleen, B cells mature into either follicular (FOB) or marginal zone (MZB) B cells. Figure 
4C shows that the FOB cell pool with IgDhiIgMhiCD21midCD23+ cells is reduced in mice with 
eIF2α phosphorylation-deficient hematopoietic cells. 
To assess the capacity of eIF2α mutant B cells to respond to mitogenic signals, purified 
splenic mutant (eIF2α-AA) and WT (eIF2α-SS) B cells were treated with different 
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concentrations of LPS and IgM F(ab)2. In vitro stimulation of sorted mutant splenic B cells 
revealed significantly decreased proliferation rates with both mitogens as compared to WT B 
cells (Figure 5A). Moreover, basal serum Ig levels of IgG1, IgG2a, IgG2b in mutant eIF2α 
µMT transplanted chimera were hardly detectable and IgM levels were strongly reduced as 
compared to WT controls (Figure 5B), indicating that development and/or function of 
antibody-secreting cells is impaired upon deficient eIF2α phosphorylation. 
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Discussion 
The role of translation initiation factors and their regulation in hematopoiesis is not well 
understood. Here we show by two independent types of hematopoietic reconstitution 
protocols that eIF2α phosphorylation at serine 51 is required for the BCR-mediated 
development and maintenance of newly formed B cells in the bone marrow and of naïve FOB 
cells in the periphery. BCR stimulation induces a short lived physiologic UPR, similar to the 
LPS-triggered UPR during the development of antibody-secreting plasma cells.18 Data 
presented here show that BCR-mediated proliferation of splenic B cells following in vitro 
stimulation through IgM F(ab)2 is markedly reduced in eIF2αAA mutant cells compared to WT 
cells. Although it remains to be addressed whether eIF2α phosphorylation is involved in the 
BCR-mediated UPR, presumably the inability to induce eIF2α phosphorylation during antigen 
stimulation results in hampered expression of components of the BCR-associated regulatory 
network. Our data thus complement a previous study showing that in a B and T cell-deficient 
BALB/c rag2-/- background the eIF2αAA mutant does not affect B cell maturation and plasma 
cell differentiation.6 In this study, the C57BL/6 WT and B cell-deficient but T cell unaffected 
µMT genetic background were used for reconstitution by eIF2αAA mutant fetal liver cells. 
After reconstitution the developing mutant B cells encounter a mixture of WT (from the 
recipients) and mutant (from the donor) T cells in both of our models. In contrary, in the 
model of Zhang and colleagues the mutant B cells encounter only mutant donor T cells. In 
addition, it has been shown that during T helper type 2 priming the regulated phosphorylation 
of eIF2α is required for activation of the integrated stress response and for cytokine secretion 
such as interleukin 4.3 Therefore, we suggest that in the model of Zhang and colleagues the 
developing mutant T cells might have a defect after priming and are not able to cause the B 
cell phenotype which we observe in our models. 
Although phosphorylation of eIF2α regulates translation initiation in all eukaryotic cells, 
eIF2α phosphorylation is apparently not essential for the development and regeneration of 
erythroid, megakaryocytic, myelo-monocytic, and myeloid lineages following stem cell 
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transplantation (Table 1 and data not shown). This is in accordance with the finding of Zhang 
and co-workers that deficiency of either IRE1α or phosphorylation of eIF2α does not affect 
hematopoietic reconstitution. Nevertheless, other studies have revealed that regulated 
phosphorylation of eIF2α probably plays distinct roles during maturation of different 
hematopoietic lineages. For example, persistent hyper-phosphorylation of eIF2α through 
knockout of the eIF2α-phosphatase PPP1R15b gene results in severe growth retardation 
and impaired erythropoiesis.2 The impaired erythropoiesis in Ppp1r15b-/- mice can be 
rescued by homozygous phosphorylation-deficient eIF2αAA alleles, indicating the 
importance of eIF2α de-phosphorylation in erythropoiesis.2 We did not observe differences in 
erythropoiesis between mice reconstituted with the eIF2αAA mutant or WT fetal liver cells, 
which is in agreement with the conclusion derived from the Ppp1r15b-/- study that de-
phosphorylation of eIF2α is an important process during erythropoiesis.  
There is increasing evidence that in cell types that have metabolic and immune functions 
cross-talk between the UPR pathway and immune responsive pathway accumulate at the 
level of eIF2α phosphorylation.3,4,19,20 Further studies using experimental inflammatory 
conditions or interference with the nutrient availability in combination with eIF2α mutations 
may further elucidate the role of UPR/eIF2α in hematopoietic cell function. 
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Table 1. Differential blood counts. 
 MIGR1 MIGR1-eIF2α-SA  eIF2α-SS eIF2α-AA 
WBC (10e9/L) 15 ± 2,8 8 ± 2,3 14,1 ± 3,2 6,5 ± 2,4 
NEU (10e9/L) 1,2 ± 0,5 1,2 ± 0,4 0,98 ± 0,16 0,94 ± 0,34 
LYM (10e9/L) 13,2 ± 2,2 6,2 ± 1,9 11,7 ± 2,4 4,4 ± 1,8 
MONO (10e9/L) 0,51 ± 0,29 0,52 ± 0,15 0,49 ± 0,34 0,54 ± 0,26 
EOS (10e9/L) 0,24 ± 0,12 0,18 ± 0,05 0,10 ± 0,07 0,09 ± 0,05 
BASO (10e9/L) 0,02 ± 0,01 0,03 ± 0,01 0,017 ± 0,008 0,015 ± 0,011 
RBC (10e12/L) 9 ± 1,1 9,7 ± 0,4 9,8 ± 0,5 9,4 ± 0,5 
HGB (g/dL) 11,43 ± 4,15 11,92 ± 4,96 14 ± 0,5 14 ± 0,7 
HCT (L/L) 0,41 ± 0,06 0,35 ± 0,13 0,47 ± 0,02 0,45 ± 0,02 
PLT (10e9/L) 978 ± 184 1161 ± 67 657 ± 142 558 ± 140 
WBC, white blood cells; NEU, neutrophils; LYM, lymphocytes; MONO, monocytes; EOS, eosinophils; 
BASO, basophils; RBC, red blood cells; HGB, hemoglobin; HCT, hematocrit; PLT, platelets; MIGR1 
(n=7); MIGR1-eIF2α-SA (n=7); eIF2α-SS (n=13), eIF2α-AA (n=13); numbers represent the mean ± 
SD. 
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Figure Legends 
Figure 1 
Reconstitution of fetal liver chimeras. (A) Scheme of retroviral transduction (MIGR1; MIGR1-
eIF2α-SA) of fetal liver cells and transplantation into C57BL/6 WT mice. (B) Percentages of 
GFP-positive cells (flow cytometry analysis) in the peripheral blood of C57BL/6 mice two and 
four months after transplantation of fetal liver cells transduced with MIGR1 and MIGR1- 
eIF2α-SA retroviral vectors (MIGR1, n=7; MIGR1-eIF2α-SA, n=6; data are shown as mean + 
SEM). (C) Immunoblotting of splenic B and non-B cells for expression of total levels of eIF2α 
and the HA tag in WT (MIGR1) and eIF2α-SA-transduced cells (MIGR1-eIF2α-SA). (D) 
Genotyping of WT (eIF2α-SS) and mutant (eIF2α-AA) fetal liver cells and transplantation into 
B cell-deficient µMT mice. (E) Flow cytometry analysis of bone marrow cells of chimeras 
reconstituted with WT (eIF2α-SS) and mutant (eIF2α-AA) fetal liver cells. CD45.2 is the 
marker of the donor cells and CD45.1 is the marker of the remaining recipient cells. (F) 
Percentages of CD45.2 positive donor cells (flow cytometry analysis) in the peripheral blood 
of chimeras one, four and ten months after transplantation (n=13 each group; data are shown 
as mean + SEM).  
 
Figure 2 
Decrease of CD19+ B cells in the peripheral blood of transplanted mice. (A) Number of white 
blood cells and lymphocytes (in 109/L) as determined by differential blood counts of mice 
after transplantation of retrovirally transduced fetal liver cells and (B) after transplantation of 
WT (eIF2α-SS) and mutant (eIF2α-AA) fetal liver cells. (C, D) Flow cytometry analysis of B 
(CD19 positive) and T (CD 90 positive) cells after transplantation at times indicated. MIGR1, 
n=7; MIGR1-eIF2α-SA, n=6; eIF2α-SS, n=14; eIF2α-AA, n=14. Data are shown as mean + 
SEM. *P-value < 0,05; **P-value < 0,001; ***P-value < 0,0001, n.s., not significant.  
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Figure 3 
Diminished mature B cells in the bone marrow of mice transplanted with eIF2α-AA (n=13) 
mutant fetal liver cells as compared to WT controls (eIF2α-SS, n=17). Flow cytometry 
analysis of pre-pro-B (A), pro-B (B), pre-B (large, small, C, D), immature (E) and mature (F) 
B cells in the bone marrow of mice transplanted with WT (eIF2α-SS; black boxes) and 
mutant (eIF2α-AA; white triangles) fetal liver cells. For discrimination of different B cell 
subsets antibodies against B220, CD43, IgM, IgD, CD24 and BP1 were used. **P-value < 
0,001. 
 
Figure 4 
Follicular B cells are reduced in mice transplanted with eIF2α-AA mutant fetal liver cells. (A) 
Spleen size and weight of mice transplanted with eIF2α-AA or eIF2α-SS fetal liver cells 
(n=10 each group). (B) Flow cytometry analysis of mononuclear splenic cells with antibodies 
against CD45.2 (donor cells), CD90 (T cells) and CD19 (B cells). Data are shown as mean + 
SEM. (C) Flow cytometry analysis of splenic B cells with antibodies against IgM, IgD, CD21 
and CD23 to discriminate between follicular (CD21hiCD23loIgMhiIgDlo, FOB) and marginal 
zone (CD21hiCD23hiIgMloIgDhi, MZB) B cells. Absolute numbers of FOB and MZB cells were 
calculated by multiplying the fraction of each B cell subset analyzed by the total number of 
CD19+ cells (data are shown as mean + SD). *P-value < 0,05; ***P-value < 0,0001; n.s., not 
significant. For B and C, n=12 each group.  
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Figure 5 
Impaired proliferative responses of splenic B cells of mice transplanted with eIF2α-AA mutant 
fetal liver cells. (A) Relative cell counts of sorted splenic B cells (eIF2α-SS, n=3, eIF2α-AA, 
n=4) after stimulation with amounts of LPS and IgM F(ab)2 as indicated (data are shown as 
mean + SEM). (B) Serum Ig concentrations in non-immunized WT (eIF2α-SS, black boxes; 
n=6) and mutant (eIF2α-AA, white triangles, n=6) mice 3 and 10 months after 
transplantation. *P-value < 0,05. 
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